MedTrace Logo

Diabetes Type 2 in the Eastern Region of Morocco

NCT04281069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 821

Last updated 2022-05-19

No results posted yet for this study

Summary

This South Initiative is the first step towards a long-term general objective that aims to improve the manage-ment of type 2 diabetes (T2D) and concurrently create jobs for health professionals in Eastern Morocco by developing a multidisciplinary approach in the management of T2D, based upon international guidelines but adapted to the regional socio-economic and cultural context, and with a focus on empowerment of Muslim women.

The intermediate results of this SI project proposal are: 1) Facilitators and perceived barriers in female patients with T2D towards change to a healthier lifestyle are known. 2) Characteristics of patients with T2D in the region of Oujda (prevalence, lifestyle, age, gender,…) are analysed. 3) Master and bachelor students have gained experience by participating to relevant research. 4) All involved stakeholders shared existing and newly ac-quired knowledge and expertise. 5) Facilitators and perceived barriers in health professionals of different disciplines to work together in the management of T2D are known.

Conditions

  • Quality of Life
  • Diabetes Mellitus, Type 2
  • Adherence, Medication
  • Diet Habit

Sponsors & Collaborators

  • Artesis Plantijn University College, Antwerp

    collaborator UNKNOWN

  • Université Mohammed Premier, Oujda

    collaborator UNKNOWN

  • Vliruos

    collaborator UNKNOWN

  • Universiteit Antwerpen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-05-18
Completion
2022-05-18

Countries

  • Morocco

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04281069 on ClinicalTrials.gov